BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perilli L, Vicentini C, Agostini M, Pizzini S, Pizzi M, D’Angelo E, Bortoluzzi S, Mandruzzato S, Mammano E, Rugge M. Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression. Oncotarget. 2014;5:6611-6619. [PMID: 25115394 DOI: 10.18632/oncotarget.2245] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Lu G, Ke X, Lu X, Wang X, Li H, Ren M, He S. miR-488 acts as a tumor suppressor gene in gastric cancer. Tumor Biol 2016;37:8691-8. [DOI: 10.1007/s13277-015-4645-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
2 Perilli L, Tessarollo S, Albertoni L, Curtarello M, Pastò A, Brunetti E, Fassan M, Rugge M, Indraccolo S, Amadori A, Bortoluzzi S, Zanovello P. Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer. BMC Cancer 2019;19:821. [PMID: 31429725 DOI: 10.1186/s12885-019-5982-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
3 Cekaite L, Eide PW, Lind GE, Skotheim RI, Lothe RA. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget. 2016;7:6476-6505. [PMID: 26623728 DOI: 10.18632/oncotarget.6390] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 10.2] [Reference Citation Analysis]
4 Jiang C, Shen F, Du J, Hu Z, Li X, Su J, Wang X, Huang X. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1. Oncotarget 2016;7:56200-8. [PMID: 27621042 DOI: 10.18632/oncotarget.8987] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
5 D'Angelo E, Fassan M, Maretto I, Pucciarelli S, Zanon C, Digito M, Rugge M, Nitti D, Agostini M. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma. Oncotarget 2016;7:28647-57. [PMID: 27081702 DOI: 10.18632/oncotarget.8725] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
6 Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang S. miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis. Cancer Res 2016;76:4293-304. [PMID: 27246830 DOI: 10.1158/0008-5472.CAN-15-3073] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
7 D'Angelo E, Zanon C, Sensi F, Digito M, Rugge M, Fassan M, Scarpa M, Pucciarelli S, Nitti D, Agostini M. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma. J Clin Pathol 2018;71:344-50. [PMID: 28870889 DOI: 10.1136/jclinpath-2017-204690] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
8 Aghagolzadeh P, Radpour R. New trends in molecular and cellular biomarker discovery for colorectal cancer. World J Gastroenterol 2016; 22(25): 5678-5693 [PMID: 27433083 DOI: 10.3748/wjg.v22.i25.5678] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
9 Pidíková P, Herichová I. miRNA Clusters with Up-Regulated Expression in Colorectal Cancer. Cancers (Basel) 2021;13:2979. [PMID: 34198662 DOI: 10.3390/cancers13122979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Liu X, Xu T, Hu X, Chen X, Zeng K, Sun L, Wang S. Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer. Cancer Manag Res. 2018;10:857-865. [PMID: 29731665 DOI: 10.2147/cmar.s158016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
11 Cao S, Lin L, Xia X, Wu H. MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1. Oncotarget. 2018;9:321-331. [PMID: 29416616 DOI: 10.18632/oncotarget.20109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
12 Li Y, Li L. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis. J Ovarian Res 2019;12:106. [PMID: 31703725 DOI: 10.1186/s13048-019-0580-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Fateh A, Feizi MAH, Safaralizadeh R, Azarbarzin S. Importance of miR-299-5p in colorectal cancer. Ann Gastroenterol 2017;30:322-6. [PMID: 28469363 DOI: 10.20524/aog.2017.0139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
14 Wang D, Liu J, Huo T, Tian Y, Zhao L. The role of microRNAs in colorectal liver metastasis: Important participants and potential clinical significances. Tumour Biol 2017;39:1010428317709640. [PMID: 28651498 DOI: 10.1177/1010428317709640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
15 Spitschak A, Meier C, Kowtharapu B, Engelmann D, Pützer BM. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit. Mol Cancer 2017;16:24. [PMID: 28122586 DOI: 10.1186/s12943-016-0563-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
16 De Matteis M, Cecchetto G, Munari G, Balsamo L, Gardiman MP, Giordano R, Viel G, Fassan M. Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected death. Leg Med (Tokyo) 2018;31:7-9. [PMID: 29220722 DOI: 10.1016/j.legalmed.2017.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
17 Bortolomeazzi M, Gaffo E, Bortoluzzi S. A survey of software tools for microRNA discovery and characterization using RNA-seq. Briefings in Bioinformatics 2019;20:918-30. [DOI: 10.1093/bib/bbx148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Vetrivel S, Zhang R, Engel M, Altieri B, Braun L, Osswald A, Bidlingmaier M, Fassnacht M, Beuschlein F, Reincke M, Chen A, Sbiera S, Riester A. Circulating microRNA Expression in Cushing's Syndrome. Front Endocrinol (Lausanne) 2021;12:620012. [PMID: 33692756 DOI: 10.3389/fendo.2021.620012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Carter JV, Galbraith NJ, Yang D, Burton JF, Walker SP, Galandiuk S. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Br J Cancer. 2017;116:762-774. [PMID: 28152545 DOI: 10.1038/bjc.2017.12] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 10.4] [Reference Citation Analysis]
20 Zhang XF, Li KK, Gao L, Li SZ, Chen K, Zhang JB, Wang D, Tu RF, Zhang JX, Tao KX. miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ. Oncotarget. 2015;6:4144-4158. [PMID: 25784653 DOI: 10.18632/oncotarget.2864] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
21 Fassan M, Saraggi D, Balsamo L, Realdon S, Scarpa M, Castoro C, Coati I, Salmaso R, Farinati F, Guzzardo V, Arcidiacono D, Munari G, Gasparini P, Veronese N, Luchini C, Valeri N, Rugge M. Early miR-223 Upregulation in Gastroesophageal Carcinogenesis. Am J Clin Pathol. 2017;147:301-308. [PMID: 28395057 DOI: 10.1093/ajcp/aqx004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
22 Galuppini F, Censi S, Moro M, Carraro S, Sbaraglia M, Iacobone M, Fassan M, Mian C, Pennelli G. MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives. Cells 2021;10:955. [PMID: 33924120 DOI: 10.3390/cells10040955] [Reference Citation Analysis]
23 Sun L, Bian G, Meng Z, Dang G, Shi D, Mi S. MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression. PLoS One 2015;10:e0124428. [PMID: 25961751 DOI: 10.1371/journal.pone.0124428] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
24 Millino C, Maretto I, Pacchioni B, Digito M, De Paoli A, Canzonieri V, D'Angelo E, Agostini M, Rizzolio F, Giordano A, Barina A, Rajendran S, Esposito G, Lanfranchi G, Nitti D, Pucciarelli S. Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy. J Cell Physiol 2017;232:426-35. [PMID: 27225591 DOI: 10.1002/jcp.25441] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
25 Dong XH, Yang XJ. Role of kinesin superfamily in gastrointestinal cancer. Shijie Huaren Xiaohua Zazhi 2018; 26(31): 1789-1794 [DOI: 10.11569/wcjd.v26.i31.1789] [Reference Citation Analysis]
26 Bernstein C, Bernstein H. Epigenetic reduction of DNA repair in progression to gastrointestinal cancer. World J Gastrointest Oncol 2015; 7(5): 30-46 [PMID: 25987950 DOI: 10.4251/wjgo.v7.i5.30] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
27 Bortoluzzi S, Lovisa F, Gaffo E, Mussolin L. Small RNAs in Circulating Exosomes of Cancer Patients: A Minireview. High Throughput 2017;6:E13. [PMID: 29485611 DOI: 10.3390/ht6040013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
28 He X, Teng J, Cui C, Li D, Wen L. MicroRNA-182 inhibits HCMV replication through activation of type I IFN response by targeting FOXO3 in neural cells. Exp Cell Res 2018;369:197-207. [PMID: 29792850 DOI: 10.1016/j.yexcr.2018.05.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
29 Fassan M, Saraggi D, Balsamo L, Cascione L, Castoro C, Coati I, De Bernard M, Farinati F, Guzzardo V, Valeri N. Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis. Oncotarget. 2016;7:4915-4924. [PMID: 26701848 DOI: 10.18632/oncotarget.6642] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
30 Niu G, Li B, Sun J, Sun L. miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met. Cell Prolif 2015;48:348-55. [PMID: 25880599 DOI: 10.1111/cpr.12187] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
31 Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Mol Carcinog. 2017;56:2669-2680. [PMID: 28767179 DOI: 10.1002/mc.22710] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
32 Hu J, Lv G, Zhou S, Zhou Y, Nie B, Duan H, Zhang Y, Yuan X. The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression. PLoS One 2015;10:e0121175. [PMID: 25973950 DOI: 10.1371/journal.pone.0121175] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
33 Qin S, Peng D, Lu J, Ke Z. MiR‐182‐5p inhibited oxidative stress and apoptosis triggered by oxidized low‐density lipoprotein via targeting toll‐like receptor 4. J Cell Physiol 2018;233:6630-7. [DOI: 10.1002/jcp.26389] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
34 Kaller M, Hermeking H. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer. In: Slaby O, Calin GA, editors. Non-coding RNAs in Colorectal Cancer. Cham: Springer International Publishing; 2016. pp. 71-92. [DOI: 10.1007/978-3-319-42059-2_4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
35 Li MW, Gao L, Dang YW, Li P, Li ZY, Chen G, Luo DZ. Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis. Cancer Cell Int 2019;19:167. [PMID: 31285693 DOI: 10.1186/s12935-019-0886-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
36 Ma Y, Liang AJ, Fan YP, Huang YR, Zhao XM, Sun Y, Chen XF. Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis. Oncotarget 2016;7:42805-25. [PMID: 27081087 DOI: 10.18632/oncotarget.8715] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
37 Sur DG, Colceriu M, Sur G, Aldea C, Silaghi C, Samasca G, Lupan I, Căinap C, Burz C, Irimie A. MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer. Expert Rev Proteomics 2019;16:851-6. [PMID: 31446809 DOI: 10.1080/14789450.2019.1659732] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
38 Saraggi D, Galuppini F, Fanelli GN, Remo A, Urso ED, Bao RQ, Bacchin D, Guzzardo V, Luchini C, Braconi C, Farinati F, Rugge M, Fassan M. MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions. Pathology - Research and Practice 2018;214:835-9. [DOI: 10.1016/j.prp.2018.04.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
39 Kai K, Dittmar RL, Sen S. Secretory microRNAs as biomarkers of cancer. Semin Cell Dev Biol. 2018;78:22-36. [PMID: 29258963 DOI: 10.1016/j.semcdb.2017.12.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
40 Wang G, Zhou F, Ou T, Sun H, Shan Z, Lu Y, Chen G, Yuan S, Zhang X, Wu S. The oncogenic role of HIF-1α/miR-182-5p/ZFP36L1 signaling pathway in nasopharyngeal carcinoma. Cancer Cell Int 2021;21:462. [PMID: 34465330 DOI: 10.1186/s12935-021-02177-3] [Reference Citation Analysis]
41 Sun L, Lin P, Chen Y, Yu H, Ren S, Wang J, Zhao L, Du G. miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism. Theranostics 2020;10:5581-99. [PMID: 32373233 DOI: 10.7150/thno.44687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Stückrath I, Rack B, Janni W, Jäger B, Pantel K, Schwarzenbach H. Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget 2015;6:13387-401. [PMID: 26033453 DOI: 10.18632/oncotarget.3874] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 11.2] [Reference Citation Analysis]
43 Nagy ZB, Wichmann B, Kalmár A, Galamb O, Barták BK, Spisák S, Tulassay Z, Molnár B. Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens. Clin Epigenetics 2017;9:22. [PMID: 28289479 DOI: 10.1186/s13148-016-0305-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]